Clinical Trials Directory

Trials / Unknown

UnknownNCT02962479

Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis?

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Eyal Kedar · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to compare biological communities in stool samples obtained from age, diet and BMI-matched subjects in five study groups: subjects with ankylosing spondylitis (AS) never treated with tumor necrosing factor (TNF) inhibitors, subjects with ankylosing spondylitis previously or currently treated with TNF inhibitors, subjects with non-radiographic axial spondyloarthritis (nrSpA) never treated with tumor necrosing factor (TNF) inhibitors, subjects with non-radiographic axial spondyloarthritis previously or currently treated with TNF inhibitors and healthy participants. The differences in fecal microbiota composition will be explored using shotgun metagenomic sequencing through the University of Washington. The investigators predict that this study will confirm a significant difference between the fecal microbiota composition (FMC) of both AS and nrSpA patients and controls.

Conditions

Timeline

Start date
2016-10-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2016-11-11
Last updated
2016-11-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02962479. Inclusion in this directory is not an endorsement.

Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis? (NCT02962479) · Clinical Trials Directory